Sprint: Virtual Care for T2-Diabetes and Obesity (Part 2)

Worldwide obesity has nearly tripled since 1975, with more than 650M obese people across the globe. As a result, the prevalence of type 2 diabetes (T2-diabetes) has increased dramatically, currently being more than 95% of all diagnosed cases of diabetes. As obesity and T2-diabetes are considerably attributed to reversible behaviours, there is a big opportunity to remotely prevent and manage these diseases and also enable regular, ongoing monitoring. Actually, T2-diabetes and obesity are two of the cardiometabolic diseases where digital health has the highest penetration and has shown more clinical and economic evidence so far.